FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4205657638> ?p ?o ?g. }

• W4205657638 abstract "Objectives 1. Determine the serotypic identities of 40 recent IBV isolates from commercial chickens raised in the USA and Israel. 2. Sequence all IBV field isolates using PCR product cycle sequencing and analyze their S 1 sequence to detennine their homology to other strains in the Genbank and EMBL databases. 3. Select vaccinal strains with the highest S 1 sequence homology to the field isolates and perform challenge of immunity studies in chickens in laboratory trials to detennine level of protection afforded by the vaccines. Background Infectious bronchitis (IB) is a common, economically important disease of the chicken. IB occurs as a respiratory form, associated with airsacculitis, condemnation, and mortality of meat-type broilers, a reproductive form responsible for egg production losses in layers and breeders, and a renal form causing high mortality in broilers and pullets. The causative agent is avian coronavirus infectious bronchitis virus (IBV). Replication of the virus' RNA genome is error-prone and mutations commonly result. A major target for mutation is the gene encoding the spike (S) envelope protein used by the virus to attach and infect the host cell. Mutations in the S gene result in antigenic changes that can lead to the emergence of variant serotypes. The S gene is able to tolerate numerous mutations without compromising the virus' ability to replicate and cause disease. An end result of the virus' flexibility is that many strains of IBV are capable of existing in nature. Once formed, new mutant strains, often referred to as variants, are soon subjected to immunological selection so that only the most antigenically novel variants survive in poultry populations. Many novel antigenic variant serotypes and genotypes have been isolated from commercial poultry flocks. Identification of the field isolates of IBV responsible for outbreaks is critical for selecting the appropriate strain(s) for vaccination. Reverse transcriptase polymerase chain reaction (RT-PCR) of the Sl subunit of the envelope spike glycoprotein gene has been a common method used to identify field strains, replacing other time-consuming or less precise tests. Two PCR approaches have been used for identification, restriction fragment length polymorphism (RFLP) and direct automated cycle sequence analysis of a diagnostically relevant hypervariab1e region were compared in our BARD research. Vaccination for IB, although practiced routinely in commercial flocks, is often not protective. Field isolates responsible for outbreaks may be unrelated to the strain(s) used in the vaccination program. However, vaccines may provide varying degrees of cross- protection vs. unrelated field strains so vaccination studies should be performed. Conclusions RFLP and S1 sequence analysis methods were successfully performed using the field isolates from the USA and Israel. Importantly, the S1 sequence analysis method enabled a direct comparison of the genotypes of the field strains by aligning them to sequences in public databases e.g. GenBank. Novel S1 gene sequences were identified in both USA and Israel IBVs but greater diversity was observed in the field isolates from the USA. One novel genotype, characterized in this project, Israel/720/99, is currently being considered for development as an inactivated vaccine. Vaccination with IBV strains in the US (Massachusetts, Arkansas, Delaware 072) or in Israel (Massachusetts, Holland strain) provided higher degrees of cross-protection vs. homologous than heterologous strain challenge. In many cases however, vaccination with two strains (only studies with US strains) produced reasonable cross-protection against heterologous field isolate challenge. Implications S1 sequence analysis provides numerical similarity values and phylogenetic information that can be useful, although by no means conclusive, in developing vaccine control strategies. Identification of many novel S1 genotypes of IBV in the USA is evidence that commercial flocks will be challenged today and in the future with strains unrelated to vaccines. In Israel, monitoring flocks for novel IBV field isolates should continue given the identification of Israel/720/99, and perhaps others in the future. Strains selected for vaccination of commercial flocks should induce cross- protection against unrelated genotypes. Using diverse genotypes for vaccination may result in immunity against unrelated field strains." @default.
• W4205657638 created "2022-01-25" @default.
• W4205657638 creator A5001935047 @default.
• W4205657638 creator A5051787854 @default.
• W4205657638 creator A5072978432 @default.
• W4205657638 creator A5077952563 @default.
• W4205657638 date "2003-12-03" @default.
• W4205657638 modified "2023-09-27" @default.
• W4205657638 title "Identification of Avian Infectious Brochitis Virus Variant Serotypes and Subtypes by PCR Product Cycle Sequencing for the Rational Selection of Effective Vaccines" @default.
• W4205657638 doi "https://doi.org/10.32747/2003.7586470.bard" @default.
• W4205657638 hasPublicationYear "2003" @default.
• W4205657638 type Work @default.
• W4205657638 citedByCount "0" @default.
• W4205657638 crossrefType "report" @default.
• W4205657638 hasAuthorship W4205657638A5001935047 @default.
• W4205657638 hasAuthorship W4205657638A5051787854 @default.
• W4205657638 hasAuthorship W4205657638A5072978432 @default.
• W4205657638 hasAuthorship W4205657638A5077952563 @default.
• W4205657638 hasBestOaLocation W42056576381 @default.
• W4205657638 hasConcept C10389963 @default.
• W4205657638 hasConcept C104317684 @default.
• W4205657638 hasConcept C134215735 @default.
• W4205657638 hasConcept C142724271 @default.
• W4205657638 hasConcept C151730666 @default.
• W4205657638 hasConcept C159047783 @default.
• W4205657638 hasConcept C2522874641 @default.
• W4205657638 hasConcept C2777020439 @default.
• W4205657638 hasConcept C2777384484 @default.
• W4205657638 hasConcept C2779134260 @default.
• W4205657638 hasConcept C2993325435 @default.
• W4205657638 hasConcept C3008058167 @default.
• W4205657638 hasConcept C524204448 @default.
• W4205657638 hasConcept C54355233 @default.
• W4205657638 hasConcept C71924100 @default.
• W4205657638 hasConcept C86803240 @default.
• W4205657638 hasConceptScore W4205657638C10389963 @default.
• W4205657638 hasConceptScore W4205657638C104317684 @default.
• W4205657638 hasConceptScore W4205657638C134215735 @default.
• W4205657638 hasConceptScore W4205657638C142724271 @default.
• W4205657638 hasConceptScore W4205657638C151730666 @default.
• W4205657638 hasConceptScore W4205657638C159047783 @default.
• W4205657638 hasConceptScore W4205657638C2522874641 @default.
• W4205657638 hasConceptScore W4205657638C2777020439 @default.
• W4205657638 hasConceptScore W4205657638C2777384484 @default.
• W4205657638 hasConceptScore W4205657638C2779134260 @default.
• W4205657638 hasConceptScore W4205657638C2993325435 @default.
• W4205657638 hasConceptScore W4205657638C3008058167 @default.
• W4205657638 hasConceptScore W4205657638C524204448 @default.
• W4205657638 hasConceptScore W4205657638C54355233 @default.
• W4205657638 hasConceptScore W4205657638C71924100 @default.
• W4205657638 hasConceptScore W4205657638C86803240 @default.
• W4205657638 hasLocation W42056576381 @default.
• W4205657638 hasOpenAccess W4205657638 @default.
• W4205657638 hasPrimaryLocation W42056576381 @default.
• W4205657638 hasRelatedWork W1974829551 @default.
• W4205657638 hasRelatedWork W1979892668 @default.
• W4205657638 hasRelatedWork W2006152309 @default.
• W4205657638 hasRelatedWork W2057314059 @default.
• W4205657638 hasRelatedWork W2160679175 @default.
• W4205657638 hasRelatedWork W2315716446 @default.
• W4205657638 hasRelatedWork W2323708605 @default.
• W4205657638 hasRelatedWork W2358758191 @default.
• W4205657638 hasRelatedWork W395015248 @default.
• W4205657638 hasRelatedWork W2163928620 @default.
• W4205657638 isParatext "false" @default.
• W4205657638 isRetracted "false" @default.
• W4205657638 workType "report" @default.